Article Details
Retrieved on: 2021-08-16 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Its biosimilars business is also growing, with revenues rising by 43% in the second quarter of 2021, driven by US demand for monoclonal antibodies ...
Article found on: www.pmlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here